arca biopharma inc (ABIO:NASDAQ CM)
Executive Profile*
Burton E. Sobel M.D.Former Director and Chairman of the Compensation Committee, Ariad Pharmaceuticals Inc. |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 7 different industries. |
| 74 | -- |
Background*
Dr. Burton E. Sobel M.D. was a Professor of the Department of Medicine for the University of Vermont College of Medicine since 1994 and also as a Professor of Biochemistry. Dr. Sobel served as Medical & Clinical Advisor of Synvista Therapeutics, Inc. Dr. Sobel had been the Editor of Circulation and Editor of Coronary Artery Disease since 1989. Dr. Sobel served as President-elect for the Society for Experimental Biology and Medicine. His research interest concerned was ...
Corporate Headquarters*8001 Arista PlaceBroomfield, Colorado 80021 United States Phone: 720-940-2200 Fax: 720-208-9261 Board Members Memberships*1996-N/A Former Director 2000-N/A Former Director 2002-2008 Former Director and Chairman of the Compensation Committee 2004-N/A Former Director, Member of Nominating & Corporate Governance Committee and Member of Audit Committee 2004-N/A Former Independent Director, Chairman of Nominating & Governance Committee and Member of Compensation Committee 2004-2013 Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 2005-2011 Former Director, Chairman of Nominating & Governance Committee and Member of Audit Committee 2007-N/A Former Director
Education*MD Harvard University Bachelor's Degree Cornell University BA Cornell University Master's Degree Brigham and Women's Hospital MD Harvard Medical School
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| ABIO:US | $2.34 USD | -0.22 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Ron Squarer BSc (Biochemistry), MBA | Chief Executive Officer and Director Array BioPharma, Inc. | $193.6K |
| Daniel R. Passeri MSc., J.D. | Chief Executive Officer and Director Curis, Inc. | $601.9K |
| Michael M. Morrissey Ph.D. | Chief Executive Officer, President and Director Exelixis, Inc. | $1.1M |
| Paul A. Friedman M.D. | Chief Executive Officer, President, Director, Member of Non-Management Stock Option Committee and Member of Finance Committee Incyte Corporation | $666.5K |
| Adelene Q. Perkins | Chairman of The Board, Chief Executive Officer and President Infinity Pharmaceuticals, Inc. | $536.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
We are currently experiencing technical difficulties. Please try again later.
Sponsored Financial Commentaries
Sponsored Links
To contact ARCA BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








